NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESNIH · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESNIH

Development of Therapeutic Products for Antibacterial Resistant Infections

Oschner, Urs (Contact)·CRESTONE, INC., CO·2019–2026·COMPLETED

Donate

INSTITUTION

CRESTONE, INC., CO

PRINCIPAL INVESTIGATOR

Oschner, Urs (Contact)

FUNDING

$3.9M

YEAR

2019

MOONBASE SCORE

Still being scored

LOADING MOONBASE SCORE

Abstract

To support the advanced development of candidate therapeutics for biodefense pathogens or emerging infectious diseases. The supported research and development activities will progress the therapeutic product development and may include lead optimization, candidate selection, preclinical and IND enabling studies, Chemistry, Manufacturing, and Controls (CMC), IND submission, clinical safety and efficacy assessment. Efforts include a Phase I clinical trial.

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESN01includecandidatetherapeuticsphaseprogressselectionoptimizationmanufacturingclinicaladvancedcontrolspreclinicalactivitiesbiodefensedevelopmentsafetyinfectioussupported

Are you the primary organization running this research?

The two tools below are built for the principal investigator & host institution behind this project.